Abstract
This research service covers the U.S. smoking cessation drug market from 2003-2013. Included are a therapeutic overview, patient forecasts, total market revenue forecasts, product revenue forecasts, and market share analysis. The market is segmented by product: Zyban, Chantix, and emerging products. Major market challenges, drivers, restraints, and strategic recommendations to overcome market challenges are also discussed.
Table of Contents
1 EXECUTIVE SUMMARY
- Executive Summary
- Introduction
2 MARKET INTRODUCTION
- Research Scope and Methodology
- Scope and Segmentation
- Research Methodology
- Smoking Overview
- Introduction
- Smoking Statistics
- Components of Cigarettes
- Reasons To Quit Smoking
- Health Risks of Smoking
- Health Benefits from Quitting Smoking
- Treatment Options
- Market Overview
- Market Engineering Measurements
- Industry Challenges
- Market Drivers
- Market Restraints
3 MARKET ANALYSIS
- Competitive Analysis
- Competitive Structure
- Product Analysis
- Zyban
- Chantix
- Emerging Products
- Emerging Smoking Cessation Drugs
- Emerging Smoking Cessation Vaccines
- Patient Forecasts
- Patient Forecasts
- Revenue Forecasts
- Total Market Revenue Forecasts
- Revenue Forecasts By Product
- Market Share Analysis
- Company Market Share
4 APPENDIX
- Decision Support Databases
- Incidence of Lung Cancer
- Prevalence of Coronary Heart Disease
- Total Cases of Stroke
- Prevalence of COPD
- Prevalence of Smokers
